Ch Kim

Ch Kim

Gilead Sciences Inc. - California / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 5680173
-
person_outline Ch Kim's MOST POPULAR ARTICLES
1-) Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpuraEM Staley, W Cao, HP Pham, CH Kim, NK Kocher, L Zheng, R Gangaraju, ...Haematologica 104 (1), 166, 2019722019
2-) Cryoprecipitate AHF vs. fibrinogen concentrates for fibrinogen replacement in acquired bleeding patients–an economic evaluationCK Okerberg, LA Williams III, ML Kilgore, CH Kim, MB Marques, ...Vox sanguinis 111 (3), 292-298, 2016642016
3-) Assessing the impact of caring for a child with Dravet syndrome: Results of a caregiver surveyJD Campbell, MD Whittington, CH Kim, GR VanderVeen, KG Knupp, ...Epilepsy & behavior 80, 152-156, 2018542018
4-) Cost-effectiveness of patent foramen ovale closure versus medical therapy for secondary stroke preventionMH Leppert, SN Poisson, JD Carroll, DE Thaler, CH Kim, KD Orjuela, ...Stroke 49 (6), 1443-1450, 2018442018
5-) ADAMTS13 test and/or PLASMIC clinical score in management of acquired thrombotic thrombocytopenic purpura: a cost‐effective analysisCH Kim, SC Simmons, LA Williams III, EM Staley, XL Zheng, HP PhamTransfusion 57 (11), 2609-2618, 2017332017